Interpretation Pitfalls

Antibody Presence Is Not Active Disease

The single most common interpretive error in serology is equating a positive antibody with current infection. IgG persists for years and signals past exposure or immunity, while IgM generally marks recent or acute infection. To distinguish active disease from immune memory, the exam expects you to use one of three strategies:

• Demonstrate IgM positivity (or an IgM-then-IgG seroconversion).
• Detect the organism directly via antigen (e.g., HBsAg, HIV p24) or nucleic acid (PCR/RNA).
• Show a fourfold rising titer between paired acute and convalescent specimens.

Worked example: A patient is rubella IgG-positive and IgM-negative. This indicates immunity from past infection or vaccination, not acute rubella. Reporting it as active infection would be a classic interpretation error.

Technical Interferences

Cold agglutinins are IgM autoantibodies that react below body temperature; they distort automated cell counts and can cause spurious agglutination in serology. Rouleaux is the stacking of red cells (seen with elevated globulins) that mimics true agglutination but disperses with saline replacement, unlike antibody-mediated agglutination.

Titer And Quality-Assurance Pitfalls

A titer is reported as the reciprocal of the highest dilution still reactive — a higher titer number means more antibody. A single titer is far less informative than a trend: only a fourfold change between paired sera is clinically significant, because one-tube (twofold) differences fall within normal assay variation.

Good quality assurance prevents most pitfalls:

• Run positive and negative controls with every batch; a failed control invalidates patient results.
• Confirm reactive screens with a more specific method before reporting (e.g., treponemal confirmation of a reactive RPR).
• Watch expiration dates and storage temperatures — degraded reagents cause false results.
• Recognize that predictive values change with prevalence: a positive screening test in a low-prevalence population is more likely a false positive, so confirmation matters most there.

Pre-Analytical And Specimen Pitfalls

• Hemolysis, lipemia, and icterus interfere with optical (turbidimetric, chemiluminescent) assays.
• Wrong specimen type or anticoagulant (e.g., heparin carryover) can invalidate certain serologic methods.
• Maternal antibody transfer can cause a falsely positive IgG in a neonate; congenital infection requires IgM (which does not cross the placenta).

Putting It Together

When a serologic result contradicts the clinical picture, work through a decision tree: Is it the wrong antibody class for the timing (IgG when you need IgM)? Is there a prozone masking a true positive? Is a heterophile or rheumatoid factor causing a false positive? Did a control fail? Is the change a true fourfold shift or just assay noise? Reasoning through these is exactly the application-and-correlation skill the MLS exam measures.

High-Yield Traps

• IgG = past/immunity; IgM = acute — never call active disease from IgG alone.
• A serology that contradicts a clear clinical picture should prompt suspicion of prozone; dilute and retest.
• Rouleaux disperses with saline; true agglutination does not.
• A fourfold titer change is significant; a single high titer or a twofold change is not.

Cross-Reactivity And False Positives

A major interpretive pitfall is cross-reactivity, where antibody raised against one antigen binds a structurally similar epitope on another. This underlies biologic false-positive non-treponemal syphilis tests (RPR/VDRL reactive in pregnancy, systemic lupus erythematosus, mononucleosis, and some viral infections without true syphilis) and the heterophile reactions of infectious mononucleosis. The correct response is always confirmation with a more specific assay — for example, a treponemal test to resolve a reactive RPR. The exam frames this as the reason screening results must never be reported as a final diagnosis.

Human anti-mouse antibodies (HAMA) in patients previously exposed to monoclonal antibody products can bridge the capture and detection antibodies of a sandwich immunoassay, producing a false-positive result. Rheumatoid factor, an IgM directed against IgG, similarly interferes with IgM-class immunoassays. Both are managed with blocking reagents and appropriate controls.

Sensitivity, Specificity, And Prevalence In Practice

Misreading test-performance statistics is a classic exam trap. A highly sensitive test, when negative, effectively rules out disease (few false negatives); a highly specific test, when positive, effectively rules in disease (few false positives). Crucially, predictive values depend on prevalence:

• In a low-prevalence population, even a good test produces a low positive predictive value — most positives are false positives, so confirmation is essential.
• In a high-prevalence population, the negative predictive value falls and a negative result is less reassuring.

Worked example: A screening immunoassay with 99% sensitivity and 99% specificity is applied to a population where true disease prevalence is 1 in 10,000. The overwhelming majority of reactive results will be false positives because the disease is so rare — illustrating why a reactive screen demands a confirmatory test before any diagnosis is reported. Candidates who ignore prevalence misjudge what a positive screen means.

Putting Pitfalls Into A Workflow

When results and clinical picture clash, escalate methodically: verify the specimen and controls, consider prozone (dilute and retest), check for cross-reactivity or interference (heterophile, rheumatoid factor, HAMA), confirm the antibody class fits the timing, and reconcile with prevalence. Only after these checks should an unexpected result be reported. This disciplined reasoning — applying knowledge, correlating to disease state, and recognizing quality-assurance failures — is precisely what the immunology questions on the MLS exam are designed to measure.

Additional Traps

• A biologic false-positive RPR is resolved with a treponemal confirmatory test, not by repeating the screen.
• HAMA and rheumatoid factor cause false-positive sandwich immunoassays; use blocking reagents.
• In low prevalence, a positive screen has low PPV — always confirm before diagnosing.
• Sensitive test negative rules out; specific test positive rules in.